The number of HLA-II positive tumor cells in breast cancer is directly associated with tumor infiltrating immune cells and levels of IFN-γ [12]–[14], but other cytokines, hormones, growth factors and oncogenes are also implicated in regulating HLA-II expression [15]–[20]. The gene discussed is IFNG; the disease is breast carcinoma.